Novartis AG and its former Alcon eye-care unit will pay more than $346 million to resolve U.S. criminal and civil charges that they bribed doctors, hospitals and clinics in Greece…

Read more »

The post Novartis, Former Unit to Pay $346 Million to Resolve U.S. Bribery Charges appeared first on Hamodia.

In related news:

  1. Trump Thanks Novartis, Pfizer for Not Raising Drug Prices
  2. Novartis Profit Slips as Generic Drug Competition Hits Sales
  3. U.S. Hedge Fund to Pay $400 Million in African Bribery Case
  4. Rolls-Royce to Pay $807 Million to End U.K., U.S. Bribery Probes
  5. FDA Approves New Heart-Failure Pill From Novartis